vimarsana.com

Latest Breaking News On - Disc medicine opco inc - Page 9 : vimarsana.com

USDD (USDD) Trading 0% Higher Over Last Week

Research Analysts’ updated eps estimates for Tuesday, May 16th: ASOS (OTCMKTS:ASOMY) had its price target trimmed by Credit Suisse Group AG from GBX 680 ($8.52) to GBX 550 ($6.89). Compass Group (OTCMKTS:CMPGY) had its price target raised by Berenberg Bank from GBX 2,100 ($26.31) to GBX 2,385 ($29.88). Comtech Telecommunications (NASDAQ:CMTL) was downgraded by analysts […]

Research Analysts Updated EPS Estimates for May 16th (ASOMY, CMPGY, CMTL, COLL, EVGO, GASS, HD, IRON, ITRN, KURA)

Research Analysts’ updated eps estimates for Tuesday, May 16th: ASOS (OTCMKTS:ASOMY) had its price target trimmed by Credit Suisse Group AG from GBX 680 ($8.52) to GBX 550 ($6.89). Compass Group (OTCMKTS:CMPGY) had its price target raised by Berenberg Bank from GBX 2,100 ($26.31) to GBX 2,385 ($29.88). Comtech Telecommunications (NASDAQ:CMTL) was downgraded by analysts […]

Disc Medicine Opco Inc (NASDAQ:IRON) to Post Q1 2023 Earnings of ($0 79) Per Share, Lifesci Capital Forecasts

Disc Medicine Opco Inc (NASDAQ:IRON – Get Rating) – Equities research analysts at Lifesci Capital issued their Q1 2023 EPS estimates for Disc Medicine Opco in a report issued on Monday, April 24th. Lifesci Capital analyst R. Katkhuda forecasts that the company will post earnings of ($0.79) per share for the quarter. Lifesci Capital has […]

Disc Medicine Opco (NASDAQ:IRON) Sets New 1-Year High at $26 76

Disc Medicine Opco Inc (NASDAQ:IRON – Get Rating)’s stock price reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $26.76 and last traded at $26.54, with a volume of 23422 shares traded. The stock had previously closed at $25.76. Wall Street Analysts Forecast Growth IRON has been […]

Disc Medicine Opco Inc (NASDAQ:IRON) Given Average Recommendation of Buy by Analysts

Shares of Disc Medicine Opco Inc (NASDAQ:IRON – Get Rating) have earned a consensus rating of “Buy” from the six brokerages that are presently covering the stock, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have issued ratings on […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.